Beurs gesloten -
Nasdaq
22:30:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,13
USD
|
+1,80%
|
|
-1,74%
|
-28,48%
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
42,78
|
25,23
|
28,5
|
47,4
|
27,39
|
21,3
|
Bedrijfswaarde
1 |
44,44
|
24,97
|
25,87
|
40,82
|
16,46
|
16,16
|
K/w-verhouding
|
-5,54
x
|
-3,27
x
|
-1,53
x
|
-4,25
x
|
-2,7
x
|
-1,36
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
-
|
14.794.283
x
|
195.104.956
x
|
12.921.260
x
|
6.249.988
x
|
Bedrijfswaarde/omzet
|
-
|
-
|
13.427.248
x
|
167.998.736
x
|
7.761.717
x
|
4.742.168
x
|
Bedrijfswaarde/EBITDA
|
-9,87
x
|
-4,32
x
|
-5,33
x
|
-4,03
x
|
-1,66
x
|
-1,37
x
|
Bedrijfswaarde/FCF
|
-
|
-6.998.792
x
|
-5.557.357
x
|
-8.046.829
x
|
-3.940.457
x
|
-1.824.026
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
-9,89
x
|
-20,4
x
|
13,8
x
|
7,24
x
|
2,85
x
|
3,41
x
|
Aantal aandelen (in duizenden)
|
3.169
|
4.498
|
7.394
|
12.001
|
16.209
|
23.919
|
Referentieprijs
2 |
13,50
|
5,610
|
3,855
|
3,950
|
1,690
|
0,8904
|
Datum van publicatie
|
12/12/18
|
20/12/19
|
9/12/20
|
15/12/21
|
22/12/22
|
15/12/23
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
-
|
1,927
|
0,243
|
2,12
|
3,408
|
EBITDA
1 |
-4,501
|
-5,786
|
-4,855
|
-10,14
|
-9,912
|
-11,76
|
Bedrijfsresultaat (EBIT)
1 |
-4,523
|
-5,813
|
-4,902
|
-10,22
|
-10,03
|
-11,96
|
Operationele Marge
|
-
|
-
|
-254,46%
|
-4.205,75%
|
-473,14%
|
-350,84%
|
Resultaat voor belastingen (EBT)
1 |
-6,844
|
-6,781
|
-13,64
|
-9,948
|
-10
|
-11,86
|
Nettowinst (verlies)
1 |
-6,844
|
-6,781
|
-13,64
|
-9,948
|
-10
|
-11,86
|
Nettomarge
|
-
|
-
|
-708%
|
-4.094,6%
|
-471,67%
|
-348,03%
|
WPA
2 |
-2,438
|
-1,716
|
-2,519
|
-0,9300
|
-0,6250
|
-0,6545
|
Free Cash Flow
|
-
|
-3,568
|
-4,655
|
-5,072
|
-4,176
|
-8,859
|
FCF-marge
|
-
|
-
|
-241,61%
|
-2.087,76%
|
-196,98%
|
-259,98%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/12/18
|
20/12/19
|
9/12/20
|
15/12/21
|
22/12/22
|
15/12/23
|
Fiscaal tijdperk: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Omzet
1 |
0,0533
|
0,0401
|
0,0366
|
0,032
|
2,011
|
1,57
|
0,4662
|
0,6299
|
0,7418
|
0,9776
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-3,453
|
-3,102
|
-3,332
|
Bedrijfsresultaat (EBIT)
1 |
-2,644
|
-2,809
|
-3,06
|
-2,761
|
-1,4
|
-1,784
|
-3,496
|
-3,51
|
-3,165
|
-3,39
|
Operationele Marge
|
-4.959,89%
|
-7.002,32%
|
-8.364,71%
|
-8.616,01%
|
-69,62%
|
-113,67%
|
-749,91%
|
-557,26%
|
-426,64%
|
-346,8%
|
Resultaat voor belastingen (EBT)
1 |
-2,643
|
-2,807
|
-3,058
|
-2,76
|
-1,374
|
-1,733
|
-3,523
|
-3,469
|
-3,135
|
-3,345
|
Nettowinst (verlies)
1 |
-2,643
|
-2,807
|
-3,058
|
-2,76
|
-1,374
|
-1,733
|
-3,523
|
-3,469
|
-3,135
|
-3,345
|
Nettomarge
|
-4.958,09%
|
-6.997,71%
|
-8.359,95%
|
-8.610,7%
|
-68,33%
|
-110,38%
|
-755,68%
|
-550,68%
|
-422,65%
|
-342,14%
|
WPA
2 |
-0,2200
|
-0,1800
|
-0,1900
|
-0,1700
|
-0,0900
|
-0,1100
|
-0,2100
|
-0,2000
|
-0,1300
|
-0,1400
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
15/12/21
|
14/02/22
|
12/05/22
|
11/08/22
|
22/12/22
|
13/02/23
|
12/05/23
|
14/08/23
|
14/12/23
|
13/02/24
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
1,66
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
0,26
|
2,63
|
6,59
|
10,9
|
5,14
|
Hefboom (schuld/ebitda)
|
-0,3696
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-3,57
|
-4,65
|
-5,07
|
-4,18
|
-8,86
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
241%
|
-3.292%
|
-231%
|
-124%
|
-150%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-967%
|
-116%
|
-101%
|
-60,4%
|
-71,4%
|
Totale activa
1 |
-
|
0,7011
|
11,78
|
9,89
|
16,56
|
16,6
|
Nettoactief per aandeel
2 |
-1,370
|
-0,2800
|
0,2800
|
0,5500
|
0,5900
|
0,2600
|
Cashflow per aandeel
2 |
0
|
0,0600
|
0,5500
|
0,5700
|
0,5000
|
0,2200
|
Capex
|
-
|
0,06
|
0,12
|
0,07
|
0,28
|
0,38
|
Capex/omzet
|
-
|
-
|
6,35%
|
27,61%
|
12,98%
|
11,27%
|
Datum van publicatie
|
12/12/18
|
20/12/19
|
9/12/20
|
15/12/21
|
22/12/22
|
15/12/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -28,48% | 29,3 mln. | | -12,91% | 19,08 mld. | | -46,21% | 2,65 mld. | | +18,15% | 1,87 mld. | | -3,12% | 1,61 mld. | | +23,78% | 1,21 mld. | | -10,69% | 1,02 mld. | | -20,89% | 905 mln. | | -7,14% | 716 mln. | | -18,10% | 682 mln. |
Medisch diagnose- & testmateriaal
|